Provided by Tiger Trade Technology Pte. Ltd.

Harvard Bioscience

0.5301
+0.03497.05%
Pre-market: 0.63000.0999+18.85%09:19 EST
Volume:125.50K
Turnover:65.66K
Market Cap:23.63M
PE:-0.43
High:0.5367
Open:0.5300
Low:0.5026
Close:0.4952
52wk High:1.43
52wk Low:0.2813
Shares:44.58M
Float Shares:33.77M
Volume Ratio:0.52
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2193
EPS(LYR):-0.2849
ROE:-135.62%
ROA:-0.82%
PB:1.68
PE(LYR):-1.86

Loading ...

Harvard Bioscience outlines strategy for growth

TIPRANKS
·
1 hour ago

Harvard Bioscience reports Q4 adjusted EBITDA of USD 3.8 million, up 27%

Reuters
·
1 hour ago

Harvard Bioscience Inc - Prelim Q4 Revenue of $23.7 Mln Above Midpoint of Guidance

THOMSON REUTERS
·
1 hour ago

Harvard Bioscience Inc - Expects Year Over Year Revenue Growth and Mid-to High-Single-Digit Ebitda Growth in 2026

THOMSON REUTERS
·
1 hour ago

Press Release: Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Dow Jones
·
1 hour ago

Harvard Bioscience files to sell 9.5M shares of common stock for holders

TIPRANKS
·
Jan 31

Harvard Bioscience Trims Footprint To Run Leaner, Faster, And Cheaper

Benzinga_recent_news
·
Jan 30

Harvard Biosciene to Close Massachusetts Manufacturing Plant

Dow Jones
·
Jan 30

Harvard Bioscience closes manufacturing operations in Massachusetts

TIPRANKS
·
Jan 30

Harvard Bioscience Inc: Certain Operations Will Also Be Relocated to Facilities in Germany, Sweden, and UK

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Inc - to Close Holliston Facility, Transition to Minneapolis - SEC Filing

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Inc - on January 23, Approves Project Viking for Strategic Consolidation - SEC Filing

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Inc - Restructuring Actions Expected Complete by First Half of 2027 - SEC Filing

THOMSON REUTERS
·
Jan 30

Harvard Bioscience: Savings Include Reduced Overhead, Improved Asset Utilization, Targeted Reconfiguration of Workforce Across Impacted Ops

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Inc - to Close Holliston Facility, Move to Minneapolis

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Inc - Expects $3 Mln Savings in 2027, $4 Mln Annually From 2028

THOMSON REUTERS
·
Jan 30

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

GlobeNewswire
·
Jan 30

Harvard Bioscience Lowers Stockholder Meeting Quorum to One-Third

Reuters
·
Jan 21

Harvard Bioscience Inc. Files Initial Beneficial Ownership Statement for Director William Snider

Reuters
·
Dec 31, 2025

Harvard Bioscience Inc - Loan Agreement Includes Term Loans Totaling $40 Mln - SEC Filing

THOMSON REUTERS
·
Dec 17, 2025